International Patent: HYDROXYMETHYLATION BIOMARKER LOCI IN THE DETECTION, MANAGEMENT, AND RECURRENCE PREDICTION OF CANCER, PARTICULARLY COLORECTAL CANCER

GENEVA, July 31 -- CLEARNOTE HEALTH, INC. filed a patent application (US2026/012224) for “HYDROXYMETHYLATION BIOMARKER LOCI IN THE DETECTION, MANAGEMENT, AND RECURRENCE PREDICTION OF CANCER, PARTICULARLY COLORECTAL CANCER”. With publication no. WO/2026/161617, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12Q 1/6886

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....